ID   PGAM1_HUMAN             Reviewed;         254 AA.
AC   P18669; Q9BWC0;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   10-MAY-2017, entry version 203.
DE   RecName: Full=Phosphoglycerate mutase 1;
DE            EC=5.4.2.11 {ECO:0000269|PubMed:23653202};
DE            EC=5.4.2.4 {ECO:0000269|PubMed:23653202};
DE   AltName: Full=BPG-dependent PGAM 1;
DE   AltName: Full=Phosphoglycerate mutase isozyme B;
DE            Short=PGAM-B;
GN   Name=PGAM1; Synonyms=PGAMA; ORFNames=CDABP0006;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=2846553;
RA   Sakoda S., Shanske S., Dimauro S., Schon E.A.;
RT   "Isolation of a cDNA encoding the B isozyme of human phosphoglycerate
RT   mutase (PGAM) and characterization of the PGAM gene family.";
RL   J. Biol. Chem. 263:16899-16905(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Leukemia;
RA   Zhou J., Yu W., Tang H., Mei G., Tsang Y.T.M., Bouck J., Gibbs R.A.,
RA   Margolin J.F.;
RT   "Pediatric leukemia cDNA sequencing project.";
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Liver, Lymph, Skin, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 2-254, AND CLEAVAGE OF INITIATOR METHIONINE.
RX   PubMed=2846554;
RA   Blouquit Y., Calvin M.C., Rosa R., Prome D., Prome J.-C.,
RA   Pratbernou F., Cohen-Solal M., Rosa J.;
RT   "Sequence of the human erythrocyte phosphoglycerate mutase by
RT   microsequencer and mass spectrometry.";
RL   J. Biol. Chem. 263:16906-16910(1988).
RN   [5]
RP   PROTEIN SEQUENCE OF 11-39; 47-61; 91-100; 118-138; 142-157; 163-176;
RP   181-191 AND 223-240, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [6]
RP   PROTEIN SEQUENCE OF 91-100.
RC   TISSUE=Mammary carcinoma;
RX   PubMed=9150946; DOI=10.1002/elps.1150180342;
RA   Rasmussen R.K., Ji H., Eddes J.S., Moritz R.L., Reid G.E.,
RA   Simpson R.J., Dorow D.S.;
RT   "Two-dimensional electrophoretic analysis of human breast carcinoma
RT   proteins: mapping of proteins that bind to the SH3 domain of mixed
RT   lineage kinase MLK2.";
RL   Electrophoresis 18:588-598(1997).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [12]
RP   ACETYLATION AT LYS-251; LYS-253 AND LYS-254, AND DEACETYLATION BY
RP   SIRT1.
RX   PubMed=22157007; DOI=10.1074/jbc.M111.317404;
RA   Hallows W.C., Yu W., Denu J.M.;
RT   "Regulation of glycolytic enzyme phosphoglycerate mutase-1 by Sirt1
RT   protein-mediated deacetylation.";
RL   J. Biol. Chem. 287:3850-3858(2012).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14 AND SER-31, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14 AND SER-23, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) IN COMPLEX WITH CITRATE,
RP   SUBUNIT, AND ACTIVE SITE.
RX   PubMed=15883004; DOI=10.1016/j.bbrc.2005.03.243;
RA   Wang Y., Wei Z., Liu L., Cheng Z., Lin Y., Ji F., Gong W.;
RT   "Crystal structure of human B-type phosphoglycerate mutase bound with
RT   citrate.";
RL   Biochem. Biophys. Res. Commun. 331:1207-1215(2005).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 1-254 IN COMPLEX WITH
RP   SUBSTRATE ANALOG, PHOSPHORYLATION AT TYR-26, ACTIVE SITE, AND
RP   CATALYTIC ACTIVITY.
RX   PubMed=23653202; DOI=10.1038/ncomms2759;
RA   Hitosugi T., Zhou L., Fan J., Elf S., Zhang L., Xie J., Wang Y.,
RA   Gu T.L., Aleckovic M., LeRoy G., Kang Y., Kang H.B., Seo J.H.,
RA   Shan C., Jin P., Gong W., Lonial S., Arellano M.L., Khoury H.J.,
RA   Chen G.Z., Shin D.M., Khuri F.R., Boggon T.J., Kang S., He C.,
RA   Chen J.;
RT   "Tyr26 phosphorylation of PGAM1 provides a metabolic advantage to
RT   tumours by stabilizing the active conformation.";
RL   Nat. Commun. 4:1790-1790(2013).
CC   -!- FUNCTION: Interconversion of 3- and 2-phosphoglycerate with 2,3-
CC       bisphosphoglycerate as the primer of the reaction. Can also
CC       catalyze the reaction of EC 5.4.2.4 (synthase), but with a reduced
CC       activity.
CC   -!- CATALYTIC ACTIVITY: 2-phospho-D-glycerate = 3-phospho-D-glycerate.
CC   -!- CATALYTIC ACTIVITY: 3-phospho-D-glyceroyl phosphate = 2,3-
CC       bisphospho-D-glycerate.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:15883004}.
CC   -!- INTERACTION:
CC       P12004:PCNA; NbExp=2; IntAct=EBI-717905, EBI-358311;
CC   -!- TISSUE SPECIFICITY: Expressed in the liver and brain. Not found in
CC       the muscle. {ECO:0000269|PubMed:2846553}.
CC   -!- PTM: Acetylated at Lys-253, Lys-253 and Lys-254 under high glucose
CC       condition. Acetylation increases catalytic activity. Under glucose
CC       restriction SIRT1 levels dramatically increase and it deacetylates
CC       the enzyme. {ECO:0000269|PubMed:22157007}.
CC   -!- SIMILARITY: Belongs to the phosphoglycerate mutase family. BPG-
CC       dependent PGAM subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J04173; AAA60071.1; -; mRNA.
DR   EMBL; AY007118; AAG01990.1; -; mRNA.
DR   EMBL; BC010038; AAH10038.1; -; mRNA.
DR   EMBL; BC011678; AAH11678.1; -; mRNA.
DR   EMBL; BC053356; AAH53356.1; -; mRNA.
DR   EMBL; BC066959; AAH66959.1; -; mRNA.
DR   EMBL; BC073742; AAH73742.1; -; mRNA.
DR   CCDS; CCDS7458.1; -.
DR   PIR; A31782; PMHUYB.
DR   RefSeq; NP_002620.1; NM_002629.3.
DR   UniGene; Hs.632918; -.
DR   PDB; 1LJD; Model; -; A=1-254.
DR   PDB; 1YFK; X-ray; 2.70 A; A/B=1-254.
DR   PDB; 1YJX; X-ray; 2.80 A; A/B/C/D/E/F/G/H/I/J/K/L=1-254.
DR   PDB; 4GPI; X-ray; 2.08 A; B/C=1-254.
DR   PDB; 4GPZ; X-ray; 1.65 A; A/B=1-254.
DR   PDBsum; 1LJD; -.
DR   PDBsum; 1YFK; -.
DR   PDBsum; 1YJX; -.
DR   PDBsum; 4GPI; -.
DR   PDBsum; 4GPZ; -.
DR   ProteinModelPortal; P18669; -.
DR   SMR; P18669; -.
DR   BioGrid; 111244; 39.
DR   IntAct; P18669; 14.
DR   MINT; MINT-3008987; -.
DR   STRING; 9606.ENSP00000359991; -.
DR   BindingDB; P18669; -.
DR   ChEMBL; CHEMBL3334418; -.
DR   DEPOD; P18669; -.
DR   iPTMnet; P18669; -.
DR   PhosphoSitePlus; P18669; -.
DR   SwissPalm; P18669; -.
DR   BioMuta; PGAM1; -.
DR   DMDM; 130348; -.
DR   DOSAC-COBS-2DPAGE; P18669; -.
DR   OGP; P18669; -.
DR   SWISS-2DPAGE; P18669; -.
DR   UCD-2DPAGE; P18669; -.
DR   EPD; P18669; -.
DR   PaxDb; P18669; -.
DR   PeptideAtlas; P18669; -.
DR   PRIDE; P18669; -.
DR   TopDownProteomics; P18669; -.
DR   DNASU; 5223; -.
DR   Ensembl; ENST00000334828; ENSP00000359991; ENSG00000171314.
DR   GeneID; 5223; -.
DR   KEGG; hsa:5223; -.
DR   CTD; 5223; -.
DR   DisGeNET; 5223; -.
DR   GeneCards; PGAM1; -.
DR   H-InvDB; HIX0036336; -.
DR   H-InvDB; HIX0120028; -.
DR   HGNC; HGNC:8888; PGAM1.
DR   HPA; HPA042528; -.
DR   HPA; HPA049237; -.
DR   HPA; HPA060483; -.
DR   MIM; 172250; gene.
DR   neXtProt; NX_P18669; -.
DR   OpenTargets; ENSG00000171314; -.
DR   PharmGKB; PA33225; -.
DR   eggNOG; KOG0235; Eukaryota.
DR   eggNOG; COG0588; LUCA.
DR   GeneTree; ENSGT00390000016700; -.
DR   HOGENOM; HOG000221682; -.
DR   HOVERGEN; HBG027528; -.
DR   InParanoid; P18669; -.
DR   KO; K01834; -.
DR   OMA; VKNQGKK; -.
DR   OrthoDB; EOG091G0GIS; -.
DR   PhylomeDB; P18669; -.
DR   TreeFam; TF300007; -.
DR   BioCyc; MetaCyc:HS10286-MONOMER; -.
DR   BRENDA; 5.4.2.11; 2681.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-70171; Glycolysis.
DR   Reactome; R-HSA-70263; Gluconeogenesis.
DR   SABIO-RK; P18669; -.
DR   SIGNOR; P18669; -.
DR   ChiTaRS; PGAM1; human.
DR   EvolutionaryTrace; P18669; -.
DR   GenomeRNAi; 5223; -.
DR   PRO; PR:P18669; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000171314; -.
DR   CleanEx; HS_PGAM1; -.
DR   ExpressionAtlas; P18669; baseline and differential.
DR   Genevisible; P18669; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0046538; F:2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity; IBA:GO_Central.
DR   GO; GO:0004082; F:bisphosphoglycerate mutase activity; IEA:UniProtKB-EC.
DR   GO; GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004619; F:phosphoglycerate mutase activity; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0061621; P:canonical glycolysis; TAS:Reactome.
DR   GO; GO:0006094; P:gluconeogenesis; IBA:GO_Central.
DR   GO; GO:0006096; P:glycolytic process; IDA:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0006110; P:regulation of glycolytic process; IDA:UniProtKB.
DR   GO; GO:0043456; P:regulation of pentose-phosphate shunt; IDA:UniProtKB.
DR   GO; GO:0045730; P:respiratory burst; IDA:UniProtKB.
DR   CDD; cd07067; HP_PGM_like; 1.
DR   Gene3D; 3.40.50.1240; -; 1.
DR   HAMAP; MF_01039; PGAM_GpmA; 1.
DR   InterPro; IPR013078; His_Pase_superF_clade-1.
DR   InterPro; IPR029033; His_PPase_superfam.
DR   InterPro; IPR001345; PG/BPGM_mutase_AS.
DR   InterPro; IPR005952; Phosphogly_mut1.
DR   PANTHER; PTHR11931; PTHR11931; 1.
DR   Pfam; PF00300; His_Phos_1; 2.
DR   SMART; SM00855; PGAM; 1.
DR   SUPFAM; SSF53254; SSF53254; 1.
DR   TIGRFAMs; TIGR01258; pgm_1; 1.
DR   PROSITE; PS00175; PG_MUTASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome;
KW   Direct protein sequencing; Glycolysis; Hydrolase; Isomerase;
KW   Phosphoprotein; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:2846554}.
FT   CHAIN         2    254       Phosphoglycerate mutase 1.
FT                                /FTId=PRO_0000179825.
FT   REGION       10     17       Substrate binding.
FT                                {ECO:0000269|PubMed:15883004,
FT                                ECO:0000269|PubMed:23653202}.
FT   REGION       23     24       Substrate binding.
FT                                {ECO:0000269|PubMed:15883004,
FT                                ECO:0000269|PubMed:23653202}.
FT   REGION       89     92       Substrate binding.
FT                                {ECO:0000269|PubMed:15883004}.
FT   REGION      116    117       Substrate binding.
FT                                {ECO:0000269|PubMed:15883004}.
FT   REGION      187    188       Substrate binding.
FT                                {ECO:0000250|UniProtKB:Q3JWH7}.
FT   COMPBIAS    122    131       Pro-rich.
FT   ACT_SITE     11     11       Tele-phosphohistidine intermediate.
FT                                {ECO:0000269|PubMed:23653202,
FT                                ECO:0000305|PubMed:15883004}.
FT   ACT_SITE     89     89       Proton donor/acceptor.
FT                                {ECO:0000305|PubMed:15883004}.
FT   BINDING      62     62       Substrate.
FT                                {ECO:0000250|UniProtKB:Q3JWH7}.
FT   BINDING     100    100       Substrate. {ECO:0000269|PubMed:15883004,
FT                                ECO:0000269|PubMed:23653202}.
FT   SITE        186    186       Transition state stabilizer.
FT                                {ECO:0000250|UniProtKB:P00950}.
FT   MOD_RES      14     14       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES      23     23       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES      26     26       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:23653202}.
FT   MOD_RES      31     31       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     106    106       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9DBJ1}.
FT   MOD_RES     118    118       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9DBJ1}.
FT   MOD_RES     251    251       N6-acetyllysine; alternate.
FT                                {ECO:0000269|PubMed:22157007}.
FT   MOD_RES     251    251       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9DBJ1}.
FT   MOD_RES     253    253       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:22157007}.
FT   MOD_RES     254    254       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:22157007}.
FT   STRAND        4     10       {ECO:0000244|PDB:4GPZ}.
FT   TURN         15     20       {ECO:0000244|PDB:4GPZ}.
FT   HELIX        32     47       {ECO:0000244|PDB:4GPZ}.
FT   STRAND       53     57       {ECO:0000244|PDB:4GPZ}.
FT   HELIX        61     73       {ECO:0000244|PDB:4GPZ}.
FT   STRAND       81     83       {ECO:0000244|PDB:4GPZ}.
FT   HELIX        85     87       {ECO:0000244|PDB:4GPZ}.
FT   HELIX        93     95       {ECO:0000244|PDB:4GPZ}.
FT   HELIX       100    107       {ECO:0000244|PDB:4GPZ}.
FT   HELIX       109    117       {ECO:0000244|PDB:4GPZ}.
FT   HELIX       133    137       {ECO:0000244|PDB:4GPZ}.
FT   HELIX       140    142       {ECO:0000244|PDB:4GPZ}.
FT   TURN        147    149       {ECO:0000244|PDB:4GPZ}.
FT   HELIX       156    170       {ECO:0000244|PDB:4GPZ}.
FT   HELIX       172    176       {ECO:0000244|PDB:4GPZ}.
FT   STRAND      181    185       {ECO:0000244|PDB:4GPZ}.
FT   HELIX       187    198       {ECO:0000244|PDB:4GPZ}.
FT   HELIX       202    207       {ECO:0000244|PDB:4GPZ}.
FT   STRAND      212    214       {ECO:0000244|PDB:1YFK}.
FT   STRAND      216    220       {ECO:0000244|PDB:4GPZ}.
FT   STRAND      226    228       {ECO:0000244|PDB:4GPZ}.
FT   HELIX       236    242       {ECO:0000244|PDB:4GPZ}.
SQ   SEQUENCE   254 AA;  28804 MW;  6DC0852BEBB22409 CRC64;
     MAAYKLVLIR HGESAWNLEN RFSGWYDADL SPAGHEEAKR GGQALRDAGY EFDICFTSVQ
     KRAIRTLWTV LDAIDQMWLP VVRTWRLNER HYGGLTGLNK AETAAKHGEA QVKIWRRSYD
     VPPPPMEPDH PFYSNISKDR RYADLTEDQL PSCESLKDTI ARALPFWNEE IVPQIKEGKR
     VLIAAHGNSL RGIVKHLEGL SEEAIMELNL PTGIPIVYEL DKNLKPIKPM QFLGDEETVR
     KAMEAVAAQG KAKK
//
